Cite
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
MLA
Cleland, Jgf, et al. Beta-Blockers for Heart Failure with Reduced, Mid-Range, and Preserved Ejection Fraction: An Individual Patient-Level Analysis of Double-Blind Randomized Trials. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....d70640350f92470cf6c874180447e549&authtype=sso&custid=ns315887.
APA
Cleland, J., Bunting, K., Flather, M., Altman, D., Holmes, J., Coats, A., Manzano, L., McMurray, J., Ruschitzka, F., van Veldhuisen, D., von Lueder, T., Böhm, M., Andersson, B., Kjekshus, J., Packer, M., Rigby, A., Rosano, G., Wedel, H., Hjalmarson, Å., … Beta-blockers in Heart Failure Collaborative Group. (2018). Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
Chicago
Cleland, Jgf, Kv Bunting, Md Flather, Dg Altman, J Holmes, Ajs Coats, L Manzano, et al. 2018. “Beta-Blockers for Heart Failure with Reduced, Mid-Range, and Preserved Ejection Fraction: An Individual Patient-Level Analysis of Double-Blind Randomized Trials,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....d70640350f92470cf6c874180447e549&authtype=sso&custid=ns315887.